-
1
-
-
0032477501
-
Overcoming the limitations of current meta-analysis of randomised controlled trials
-
Pogue J, Yusuf S,. Overcoming the limitations of current meta-analysis of randomised controlled trials. Lancet 1998; 351: 47-52.
-
(1998)
Lancet
, vol.351
, pp. 47-52
-
-
Pogue, J.1
Yusuf, S.2
-
2
-
-
0028152471
-
Systematic review: Why sources of heterogeneity in meta-analysis should be investigated
-
Thompson SG,. Systematic review: why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994; 309: 1351-5.
-
(1994)
BMJ
, vol.309
, pp. 1351-1355
-
-
Thompson, S.G.1
-
3
-
-
0025748061
-
Effects of intravenous magnesium in suspected acute myocardial infarction: Overview of randomised trials
-
Teo KK, Yusuf S, Collins R, Held P, Peto R,. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. BMJ 1991; 303: 1499-503.
-
(1991)
BMJ
, vol.303
, pp. 1499-1503
-
-
Teo, K.K.1
Yusuf, S.2
Collins, R.3
Held, P.4
Peto, R.5
-
4
-
-
0028932732
-
ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction
-
Forth International Study of Infarct Survival Collaborative Group.
-
Forth International Study of Infarct Survival Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669-85.
-
(1995)
Lancet
, vol.345
, pp. 669-685
-
-
-
5
-
-
0028926350
-
Randomized trials of magnesium in acute myocardial infarction: Big numbers do not tell the whole story
-
Antman EM,. Randomized trials of magnesium in acute myocardial infarction: big numbers do not tell the whole story. Am J Cardiol 1995; 5: 391-3.
-
(1995)
Am J Cardiol
, vol.5
, pp. 391-393
-
-
Antman, E.M.1
-
6
-
-
84863689054
-
Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: The RED-CABG randomized controlled trial
-
Newman MF, Ferguson TB, White JA, et al. Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial. JAMA 2012; 2: 157-64.
-
(2012)
JAMA
, vol.2
, pp. 157-164
-
-
Newman, M.F.1
Ferguson, T.B.2
White, J.A.3
-
7
-
-
0031021506
-
Effects of acadesine on myocardial infarction, stroke and death, following surgery: A meta-analysis of the 5 international randomized trials
-
Multicenter Study of Perioperative Ischemia (McSPI) Research Group.
-
Mangano DT, Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Effects of acadesine on myocardial infarction, stroke and death, following surgery: a meta-analysis of the 5 international randomized trials. JAMA 1997; 4: 325-32.
-
(1997)
JAMA
, vol.4
, pp. 325-332
-
-
Mangano, D.T.1
-
8
-
-
34347394385
-
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
-
Hart RG, Pearce LA, Aguilar MI,. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-67.
-
(2007)
Ann Intern Med
, vol.146
, pp. 857-867
-
-
Hart, R.G.1
Pearce, L.A.2
Aguilar, M.I.3
-
9
-
-
1842376945
-
Discrepancies between meta-analyses and subsequent large randomized controlled trials
-
LeLorier J, Gregorie G, Benhaddad A, Lapierre J, Derderian F., Discrepancies between meta-analyses and subsequent large randomized controlled trials. N Engl J Med 1997; 337: 536-42.
-
(1997)
N Engl J Med
, vol.337
, pp. 536-542
-
-
Lelorier, J.1
Gregorie, G.2
Benhaddad, A.3
Lapierre, J.4
Derderian, F.5
-
10
-
-
48749100385
-
Autologous bone marrow stem cells to treat acute myocardial infarction: A systematic review
-
Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM,. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 2008; 15: 1807-18.
-
(2008)
Eur Heart J
, vol.15
, pp. 1807-1818
-
-
Martin-Rendon, E.1
Brunskill, S.J.2
Hyde, C.J.3
Stanworth, S.J.4
Mathur, A.5
Watt, S.M.6
-
12
-
-
0036401876
-
Intermittentpneumatic compression for the treatment of lower extremity arterial disease: A systematic review
-
Labropoulos N, Wierks C, Suffoletto B,. Intermittentpneumatic compression for the treatment of lower extremity arterial disease: a systematic review. Vasc Med 2002; 7: 141-8.
-
(2002)
Vasc Med
, vol.7
, pp. 141-148
-
-
Labropoulos, N.1
Wierks, C.2
Suffoletto, B.3
-
13
-
-
77949911267
-
A prospective randomized controlled study with intermittent mechanical compression of the calf in patients with claudication
-
de Haro J, Acin F, Florez A, Bleda S, Fernandez JL,. A prospective randomized controlled study with intermittent mechanical compression of the calf in patients with claudication. J Vasc Surg 2010; 51: 857-62.
-
(2010)
J Vasc Surg
, vol.51
, pp. 857-862
-
-
De Haro, J.1
Acin, F.2
Florez, A.3
Bleda, S.4
Fernandez, J.L.5
-
14
-
-
0036044522
-
Prophilactic intravenous indomethacin for preventing mortality and morbidity in preterm infants
-
Fowlie PW, Davis PG., Prophilactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2002; 3: cd000174.
-
(2002)
Cochrane Database Syst Rev
, vol.3
-
-
Fowlie, P.W.1
Davis, P.G.2
-
15
-
-
47049124038
-
Increased indomethacin dosing for the persistent patent ductus arteriosus in preterm infants: A multicenter, randomized, controlled trial
-
Jegatheesan P, Ianus V, Buchn B, et al. Increased indomethacin dosing for the persistent patent ductus arteriosus in preterm infants: a multicenter, randomized, controlled trial. J Pediatr 2008; 152: 183-9.
-
(2008)
J Pediatr
, vol.152
, pp. 183-189
-
-
Jegatheesan, P.1
Ianus, V.2
Buchn, B.3
-
17
-
-
84864219466
-
N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia
-
ORIGIN Trial investigators, et al.
-
ORIGIN Trial investigators, Bosch J, Gerstein HC, Dagenais G, et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012; 367: 309-18.
-
(2012)
N Engl J Med
, vol.367
, pp. 309-318
-
-
Bosch, J.1
Gerstein, H.C.2
Dagenais, G.3
-
18
-
-
0033818456
-
Vitamin supplements and cardiovascular risk: Review of the randomized trials of homocysteine-lowering vitamin supplements
-
Clarke R, Armitage J,. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Semin Thromb Hemost 2000; 26: 341-8.
-
(2000)
Semin Thromb Hemost
, vol.26
, pp. 341-348
-
-
Clarke, R.1
Armitage, J.2
-
19
-
-
77953867844
-
Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: A randomized trial
-
SEARCH Collaborative Group, et al.
-
SEARCH Collaborative Group, Armitage J, Bowman L, Clarke RJ, et al. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA 2010; 303: 2486-94.
-
(2010)
JAMA
, vol.303
, pp. 2486-2494
-
-
Armitage, J.1
Bowman, L.2
Clarke, R.J.3
-
20
-
-
0029931362
-
Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease
-
Marchioli R, Marfisi RM, Carinci F, Tognoni G,. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease. Arch Intern Med 1996; 156: 1158-72.
-
(1996)
Arch Intern Med
, vol.156
, pp. 1158-1172
-
-
Marchioli, R.1
Marfisi, R.M.2
Carinci, F.3
Tognoni, G.4
-
21
-
-
0037031061
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: A randomised placebo-controlled trial
-
Heart Protection Study Collaborative Group.
-
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
-
(2002)
Lancet
, vol.360
, pp. 7-22
-
-
|